Ingrezza
Payments companies reported to CMS as associated with Ingrezza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ingrezza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ingrezza
These are the largest totals companies reported as associated with Ingrezza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Amy Lacouture | Baton Rouge, LA | Psychiatric/Mental Health (Nurse Practitioner) | $429,889.17 |
| Bisena Bulica | Detroit, MI | Neurology (Psychiatry & Neurology) | $401,325.21 |
| Fiona Gupta | Oradell, NJ | Neurology (Psychiatry & Neurology) | $393,199.88 |
| Larry Warner | Baton Rouge, LA | Psychiatry | $391,987.54 |
| Mark Reynolds | Durham, NC | Psychiatry | $384,398.39 |
| Rakesh Amin | Nashville, TN | Psychiatry | $384,303.53 |
| Ilan Melnick | Coral Gables, FL | Psychiatry | $378,697.73 |
| Jennifer Mondillo | Schwenksville, PA | Adult Health (Nurse Practitioner) | $377,613.80 |
| Mazhar Khowaja | Houston, TX | Psychiatry | $374,380.80 |
| Melissa Moody | Charleston, WV | Psychiatry | $368,485.49 |
Prescribed Ingrezza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.